MetaVia, Inc. (MTVA)
1.29
+0.06
(+4.88%)
USD |
NASDAQ |
Oct 20, 16:00
1.27
-0.02
(-1.55%)
After-Hours: 06:53
MetaVia EPS Diluted (Quarterly) : -0.8962 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8962 |
| March 31, 2026 | -0.7867 |
| December 31, 2025 | -0.8361 |
| September 30, 2025 | -1.521 |
| June 30, 2025 | -2.875 |
| March 31, 2025 | -0.3577 |
| December 31, 2024 | -6.588 |
| September 30, 2024 | -0.5534 |
| June 30, 2024 | -1.852 |
| March 31, 2024 | -1.319 |
| December 31, 2023 | -1.046 |
| September 30, 2023 | -0.7522 |
| June 30, 2023 | -0.1451 |
| March 31, 2023 | -0.5147 |
| December 31, 2022 | -1.471 |
| September 30, 2022 | -28.02 |
| June 30, 2022 | -29.73 |
| March 31, 2022 | -25.88 |
| December 31, 2021 | -41.21 |
| September 30, 2021 | -37.27 |
| June 30, 2021 | -42.39 |
| March 31, 2021 | -36.91 |
| Date | Value |
|---|---|
| December 31, 2020 | -238.03 |
| September 30, 2020 | -44.62 |
| June 30, 2020 | -35.09 |
| March 31, 2020 | -72.44 |
| December 31, 2019 | -171.79 |
| September 30, 2019 | -46394.70 |
| June 30, 2019 | -24142.80 |
| March 31, 2019 | -31474.74 |
| December 31, 2018 | -1537.68 |
| September 30, 2018 | -2557.86 |
| June 30, 2018 | -2815.26 |
| March 31, 2018 | -3484.38 |
| December 31, 2017 | -3780.00 |
| September 30, 2017 | -4920.00 |
| June 30, 2017 | -5940.00 |
| March 31, 2017 | -4740.00 |
| December 31, 2016 | -4680.00 |
| September 30, 2016 | -3360.00 |
| June 30, 2016 | -2520.00 |
| March 31, 2016 | -1521.36 |
| March 31, 2015 | -3239.94 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
| Vericel Corp. | 0.0422 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.316M |
| Total Expenses (Quarterly) | 5.316M |
| Enterprise Value | -3.974M |
| Earnings Yield | -313.2% |
| Normalized Earnings Yield | -313.91 |